ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 1.750
-2.350 (-57.32%)
At close: Sep 18, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 53.18 million as of September 18, 2026. Its market cap has decreased by -64.05% in one year.
Market Cap
53.18M
Enterprise Value
52.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.75
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 53.18M, an increase of 268.51%. That is a compound annual growth rate of 55.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 53.18M | -55.76% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 275.81M |
| Eastwood Bio-Medical Canada | 123.99M |
| Helix BioPharma | 106.93M |
| NurExone Biologic | 57.84M |
| MedMira | 45.61M |
| Sona Nanotech | 44.21M |
| BriaCell Therapeutics | 43.32M |
| Sharp Therapeutics | 43.26M |